Page last updated: 2024-08-16

sarpogrelate and d-alpha tocopherol

sarpogrelate has been researched along with d-alpha tocopherol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arockia Rani P, J; Fukatsu, A; Hayashi, T; Iguchi, A; Kano, H; Matsui-Hirai, H; Sumi, D; Tsunekawa, T	1

Other Studies

1 other study(ies) available for sarpogrelate and d-alpha tocopherol

Article	Year
Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism. Atherosclerosis, 2003, Volume: 168, Issue:1 Topics: Acetylcholine; Animals; Antioxidants; Aorta, Thoracic; Biomarkers; Blood Proteins; Cholesterol, HDL; Coronary Artery Disease; Cyclic GMP; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypercholesterolemia; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Models, Cardiovascular; Myocardial Contraction; Myocytes, Smooth Muscle; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rabbits; RNA, Messenger; Serotonin Antagonists; Succinates; Treatment Outcome; Vasodilator Agents; Vitamin E	2003

Article

Year

Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism.

Atherosclerosis, 2003, Volume: 168, Issue:1

Topics: Acetylcholine; Animals; Antioxidants; Aorta, Thoracic; Biomarkers; Blood Proteins; Cholesterol, HDL; Coronary Artery Disease; Cyclic GMP; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypercholesterolemia; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Models, Cardiovascular; Myocardial Contraction; Myocytes, Smooth Muscle; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rabbits; RNA, Messenger; Serotonin Antagonists; Succinates; Treatment Outcome; Vasodilator Agents; Vitamin E

2003